Results 191 to 200 of about 30,055 (235)

Cholecystokinin receptor antagonists

Journal of Surgical Research, 1988
K A, Zucker, T E, Adrian, I M, Modlin
openaire   +2 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.

Progress in clinical and biological research, 1986
It has previously been shown that cholecystokinin octapeptide (CCK-8) can modulate the binding of dopaminergic agonists and antagonists to brain homogenates in vitro. The present study was designed to more carefully address the possibility that CCK-8 could modulate the number of affinity of rat striatal D2 receptors.
openaire   +1 more source

Cholecystokinin type A receptor

AfCS-Nature Molecule Pages, 2006
openaire   +1 more source

Quinazolinone cholecystokinin-B receptor ligands

Journal of Medicinal Chemistry, 1991
M J, Yu, K J, Thrasher, J R, McCowan, N R, Mason, L G, Mendelsohn   +4 more
openaire   +2 more sources

Cholecystokinin receptor antagonists

Neuropeptides, 1992
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

[Cholecystokinin receptors].

Gastroenterologie clinique et biologique, 1992
C, Nagain, C, Rozé
openaire   +1 more source

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly